Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: P...

FDA Recall #D-0575-2025 — Class II — July 29, 2025

Recall #D-0575-2025 Date: July 29, 2025 Classification: Class II Status: Ongoing

Product Description

Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.

Reason for Recall

Subpotent drug

Recalling Firm

Pfizer — Manhattan, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

29, 004 bottles

Distribution

Within U.S

Code Information

Lot #: 24C11, Exp 2/28/2026.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated